Calculate Your Salary Ranking
Home > InteKrin Therapeutics Salary

InteKrin Therapeutics Salary
  • 94
  • 44
  • 70

InteKrin Therapeutics average salary is $-, median salary is $- with a salary range from $- to $-.
InteKrin Therapeutics salaries are collected from government agencies and companies. Each salary is associated with a real job position. InteKrin Therapeutics salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 0 InteKrin Therapeutics Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More Info
Calculate how much you could earn

It's FREE. Based on your input and our analysis.    How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address
Recent InteKrin Therapeutics Salaries (February 22, 2017)
Assistant Professor University of Oklahoma $42,860 Norman, OK, 73019 01/05/2015
General OMRON $65,998 Houston, TX, 77001 09/07/2015

InteKrin Therapeutics salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
InteKrin Therapeutics Information
  • InteKrin Therapeutics Inc
  • Industry: BioTech/Drugs
  • City: Los Altos, CA
  • InteKrin Therapeutics is a clinical-stage, privately held BioPharma company focused on developing and commercializing breakthrough therapeutics for neuroendocrine, metabolic, and immune disorders. Diseases such as diabetes, metabolic syndrome, and cancer are increasingly in need of novel treatments that provide patients with better treatment alternatives and help to curb soaring healthcare costs. The company is in the process of in-licensing early- and late-stage compounds that have the potential to unlock the complex hormonal relationship between metabolism, insulin resistance, and obesity. More information coming soon.